Martorano L, Erwin EA. Aeroallergen Exposure and Spread in the Modern Era. J Allergy Clin Immunol Pract. 2018;6:1835–42.
Akar-Ghibril N, Casale T, Custovic A, et al. Allergic Endotypes and Phenotypes of Asthma. J Allergy Clin Immunol Pract. 2020;8:429–40.
PubMed PubMed Central Google Scholar
Farrokhi S, Gheybi MK, Movahed A, et al. Common aeroallergens in patients with asthma and allergic rhinitis living in southwestern part of Iran: based on skin prick test reactivity. Iran J Allergy Asthma Immunol. 2015;14:133–8.
Craig TJ. Aeroallergen sensitization in asthma: prevalence and correlation with severity. Allergy Asthma Proc. 2010;31:96–102.
Eiringhaus K, Renz H, Matricardi P, et al. Component-Resolved Diagnosis in Allergic Rhinitis and Asthma. J Appl Lab Med. 2019;3:883–98.
Peters N, Peters AT. Atopic dermatitis. Allergy Asthma Proc. 2019;40:433–6.
Tamagawa-Mineoka R, Katoh N. Atopic Dermatitis: Identification and Management of Complicating Factors. Int J Mol Sci. 2020;21:E2671.
Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124:1251-1258.e23.
Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132:1132–8.
Sandhu JK, Wu KK, Bui T-L, et al. Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019;155:178–87.
David Boothe W, Tarbox JA, Tarbox MB. Atopic Dermatitis: Pathophysiology. Adv Exp Med Biol. 2017;1027:21–37.
Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in US. J Invest Dermatol. 2013;133:1752–9.
CAS PubMed PubMed Central Google Scholar
•• Werfel T, Heratizadeh A, Niebuhr M, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol 2015; 136:96–103.e9. The first double-blind placebo-controlled study which confirmed aeroallergens as a direct trigger in atopic dermatitis.
Badorrek P, Dick M, Emmert L, et al. Pollen starch granules in bronchial inflammation. Ann Allergy Asthma Immunol. 2012;109:208-14.
van der Heijden FL, Joost van Neerven RJ, van Katwijk M, et al. Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol. 1993;150:3643–3650.
Maurer D, Ebner C, Reininger B, et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol. 1995;154:6285–90.
Sharquie IK, Al-Ghouleh A, Fitton P, et al. An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells. BMC Immunol. 2013;14:54.
PubMed PubMed Central Google Scholar
Novak N, Bieber T, Kraft S. Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis. Curr Allergy Asthma Rep. 2004;4:263–9.
Cooper D, Hales J, Camp R. IgE-Dependent Activation of T cells by Allergen in Atopic Dermatitis: Pathophysiologic Relevance. J Investig Dermatol. 2004;123:1086–91.
Campana R, Dzoro S, Mittermann I, et al. Molecular aspects of allergens in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2017;17:269–77.
CAS PubMed PubMed Central Google Scholar
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345–60.
Oetjen LK, Mack MR, Feng J, et al. Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch. Cell. 2017;171:217-228.e13.
CAS PubMed PubMed Central Google Scholar
Gandhi NA, Bennett BL, Graham NMH, et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15:35–50.
Werfel T, Breuer K, Ruéff F, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy. 2006;61:202–5.
Hijnen D, Knol EF, Gent YY, et al. CD8+ T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17 and IL-22. J Invest Dermatol 2013;133. https://doi.org/10.1038/jid.2012.456.
Trautmann A, Akdis M, Kleemann D, et al. T cell–mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest. 2000;106:25–35.
CAS PubMed PubMed Central Google Scholar
De Benedetto A, Rafaels NM, McGirt LY, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127(773–786):e1-7.
Yoshida K, Kubo A, Fujita H, et al. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. J Allergy Clin Immunol. 2014;134:856–64.
Brandner JM, Zorn-Kruppa M, Yoshida T, et al. Epidermal tight junctions in health and disease. Tissue Barriers. 2015;3: e974451.
Lee CH, Chuang HY, Hong CH, et al. Lifetime exposure to cigarette smoking and the development of adult-onset atopic dermatitis. Br J Dermatol. 2011;164:483–9.
CAS PubMed PubMed Central Google Scholar
Endo K, Hizawa T, Fukuzumi T, et al. [Keeping dogs indoor aggravates infantile atopic dermatitis]. Arerugi. 1999;48: 1309–1315.
Jaworek AK, Szafraniec K, Jaworek M, et al. Cat Allergy as a Source Intensification of Atopic Dermatitis in Adult Patients. Adv Exp Med Biol. 2020;1251:39–47.
Pónyai G, Hidvégi B, Németh I, et al. Contact and aeroallergens in adulthood atopic dermatitis. J Eur Acad Dermatol Venereol. 2008;22:1346–55.
Kutlu A, Karabacak E, Aydin E, et al. Relationship between skin prick and atopic patch test reactivity to aeroallergens and disease severity in children with atopic dermatitis. Allergol Immunopathol. 2013;41:369–73.
Tan BB, Weald D, Strickland I, et al. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet. 1996;347:15–8.
Oosting A-J, de Bruin-Weller MS, Terreehorst I, et al. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol. 2002;110:500–6.
Kim J, Lee S, Woo S, et al. The Indoor Level of House Dust Mite Allergen Is Associated with Severity of Atopic Dermatitis in Children. J Korean Med Sci. 2013;28:74–9.
PubMed PubMed Central Google Scholar
Sanda T, Yasue T, Oohashi M, et al. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol. 1992;89:653–7.
Colloff MJ, Lever RS, McSharry C. A controlled trial of house dust mite eradication using natamycin in homes of patients with atopic dermatitis: effect on clinical status and mite populations. Br J Dermatol. 1989;121:199–208.
Holm L, Bengtsson A, van Hage-Hamsten M, et al. Effectiveness of occlusive bedding in the treatment of atopic dermatitis–a placebo-controlled trial of 12 months’ duration. Allergy. 2001;56:152–8.
Katoh N, Hirano S, Suehiro M, et al. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Clin Exp Immunol. 2000;121:187–92.
CAS PubMed PubMed Central Google Scholar
Novak N, Bieber T, Hoffmann M, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol. 2012;130:925-931.e4.
Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol. 2007;120:164–70.
•• Langer SS, Cardili RN, Melo JML, et al. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice. Epub ahead of print 10 November 2021. https://doi.org/10.1016/j.jaip.2021.10.060. A double-blind placebo-controlled trial showing the efficacy of house dust mite sublingual immunotherapy in atopic dermatitis.
Patella V, Florio G, Palmieri M, et al. Atopic dermatitis severity during exposure to air pollutants and weather changes with an Artificial Neural Network (ANN) analysis. Pediatr Allergy Immunol. 2020;31:938–45.
•• Wassmann-Otto A, Heratizadeh A, Wichmann K, et al. Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis. Allergy 2018; 73: 2046–2054. Interesting study showing the trigger of atopic dermatitis by pollen-related foods.
Reekers R, Busche M, Wittmann M, et al. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol. 1999;104:466–72.
Heratizadeh A, Wichmann K, Werfel T. Food allergy and atopic dermatitis: how are they connected? Curr Allergy Asthma Rep. 2011;11:284–91.
Anderson LB, Dreyfuss EM, Logan J, et al. Melon and banana sensitivity coincident with ragweed pollinosis. J Allergy. 1970;45:310–9.
Antia C, Baquerizo K, Korman A, et al. Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up. J Am Acad Dermatol. 2018;79:599–614.
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393–414.
Hon KL, Leung AKC, Ng WGG, et al. Chronic Urticaria: An Overview of Treatment and Recent Patents. Recent Pat Inflamm Allergy Drug Discov. 2019;13:27–37.
CAS PubMed PubMed Central Google Scholar
Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy. 2005;60:1073–8.
Staubach P, Eckhardt-Henn A, Dechene M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. 2006;154:294–
留言 (0)